GLP-1 Medications for Weight Loss Now Available!
The city of Little Rock, Arkansas, currently has 1 active clinical trials seeking participants for Weight Loss research studies.
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight
This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight
Read Less
Trial Updated:
08/12/2025
Locations: Viking Clinical Site #2036, Little Rock, Arkansas
Viking Clinical Site #2036, Little Rock, Arkansas